SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-050850
Filing Date
2021-10-14
Accepted
2021-10-14 16:15:52
Documents
19
Period of Report
2021-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K FOR OCTOBER 12, 2021 FOLLOW-ON FINANCING rlay-8k_20211011.htm   iXBRL 8-K 52241
2 EX-1.1 rlay-ex11_24.htm EX-1.1 329785
3 EX-5.1 rlay-ex51_23.htm EX-5.1 12722
4 EX-99.1 rlay-ex991_6.htm EX-99.1 11835
5 EX-99.2 rlay-ex992_7.htm EX-99.2 12687
6 GRAPHIC g2xo2d2woxhu000001.jpg GRAPHIC 6869
7 GRAPHIC gy5fy55chsjz000001.jpg GRAPHIC 2077
8 GRAPHIC g0k5hect1vdt000001.jpg GRAPHIC 6869
  Complete submission text file 0001564590-21-050850.txt   656511

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA rlay-20211011.xsd EX-101.SCH 5665
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlay-20211011_lab.xml EX-101.LAB 20069
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlay-20211011_pre.xml EX-101.PRE 11919
12 EXTRACTED XBRL INSTANCE DOCUMENT rlay-8k_20211011_htm.xml XML 3696
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39385 | Film No.: 211323525
SIC: 2836 Biological Products, (No Diagnostic Substances)